> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Renovis Surgical Fusion System
- URL: https://www.fdaweb.com/fda-clears-renovis-surgical-fusion-system/
- Published: 2017-08-11T12:00:00.000Z
- Updated: 2026-09-14T22:40:43.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139366

FDA has cleared a Renovis Surgical Technologies 510(k) to market posterior lumbar Tesera porous titanium interbody fusion systems. The device line features implants for direct posterior or transforaminal approaches in both straight and curved options, according to the company. Multiple heights, widths and lengths are available to better fit varying patient anatomies. The implants are produced through additive manufacturing (3D printing) using the company’s proprietary Tesera Trabecular Technology, a “highly porous structure that allows for bone attachment to implant surfaces and the potential for biologic fixation deep into the pore structure for long-term stability,” it says.